Key terms

About YCBD

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest YCBD news

Dec 14 6:03am ET cbdMD Wins Awards in Two Categories at Prestigious Best in Biz Awards Oct 25 1:50pm ET cbdMD Announces Cancellation of Special Meeting Oct 05 5:00am ET cbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer Team Sep 22 1:02pm ET cbdMD Announces Adjournment of Special Meeting Sep 22 5:58am ET Breaking Barriers: cbdMD's Research Validates Safe CBD Upper Dose Sep 14 8:48am ET Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline of 1:00 p.m. (Eastern time) on September 22, 2023 Aug 25 5:00am ET Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award Aug 22 4:30am ET cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock Aug 18 10:23am ET cbdMD Responds to Congressional Request for Information (RFI) on Regulation of CBD Products Aug 10 12:48pm ET cbdMD Demonstrates Strong Year-over-Year Performance, Significantly Reducing Net Loss by $30 Million Aug 07 6:00am ET cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results Aug 03 5:00am ET cbdMD Releases Tropical Hemp-derived THC + CBD Gummy Line to Elevate Consumer Wellness Jun 29 10:25am ET cbdMD Announces Migration to E-Commerce Platform, Shopify Jun 22 5:00am ET cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega May 15 12:10pm ET cbdMD Stabilizes Revenue and Significantly Improves Operating Results May 10 10:59am ET cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2023 Results May 03 10:02am ET cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock Apr 30 4:51pm ET cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock Apr 28 12:49pm ET cbdMD Announces Proposed Public Offering of Common Stock Apr 18 7:50am ET cbdMD's Clinical Study Supports Improved Mobility in Dogs Apr 14 12:05pm ET cbdMD, Inc. Announces One-for-Forty Five Reverse Stock Split of Its Common Stock Apr 12 7:57am ET cbdMD Expands its Reach to The United Kingdom with Launch on Amazon UK Feb 16 4:52am ET cbdMD to Present at NutraIngredients-USA's Sports and Active Nutrition Summit Feb 13 11:10am ET cbdMD Posts $15 Million in Net Income Improvement over Prior Year Quarter Feb 13 6:24am ET cbdMD Receives $1 Million Return of Capital Following Closing of Adara SPAC Transaction Feb 06 11:05am ET cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2023 Results Jan 26 11:47am ET cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News Jan 11 7:33am ET cbdMD Welcomes Shannon Charles as Chief Marketing Officer

YCBD Financials

1-year income & revenue

Key terms

YCBD Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

YCBD Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms